This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Oppenheimer Strengthens Healthcare Investment Banking Team By Adding Five Bankers, Including Marc Cabrera As Head Of Healthcare Services

Stocks in this article: OPY

Oppenheimer & Co. Inc., a unit of Oppenheimer Holdings (NYSE:OPY), today announced that Marc Cabrera has joined its Healthcare Investment Banking Group as Managing Director and Head of Healthcare Services. Cabrera joins Oppenheimer as part of a team of five healthcare bankers that includes John Cramer, Managing Director and Michael Holland, Executive Director. Cabrera and his team will continue their coverage of the healthcare services, managed care, HCIT, specialty pharmaceuticals and medical technology sectors from Oppenheimer’s New York and Miami offices.

"Marc adds a critical dimension to our healthcare group, which is a market-leading platform across life sciences, medical technology and healthcare services," said Bruce McCarthy, Co-Head of Investment Banking for Oppenheimer. "Marc brings deep knowledge of the managed care and provider services sectors to our firm and was involved in some of last year’s most notable healthcare services transactions including Metropolitan Health’s $850 million sale to Humana, Healthfirst’s acquisition of Neighborhood Health Providers and SeniorBridge’s sale to Humana. Over the past several years, Marc advised on over a dozen marquis healthcare services deals and has been at the forefront of payor-provider integration.”

“We’re excited to bring on board the whole team because they strengthen one of Oppenheimer’s key sector franchises,” said Marc Thompson, Co-Head of Investment Banking. “John adds critical coverage in HCIT, an important sector for Oppenheimer, and some terrific recent experience having advised Stanley Black & Decker on its acquisition of AeroScout. They will clearly enhance our ability to deliver best execution for our clients."

All five healthcare bankers joined Oppenheimer from Morgan Joseph, where Cabrera ran the healthcare group as one of the firm’s most senior partners and Cramer was a senior coverage banker in services and HCIT. Previously, Cabrera was a senior member of Bear Stearns’ Healthcare Group and began his career in Smith Barney’s Mergers & Acquisitions Group. Cramer was previously with Gleacher & Co. and Robertson Stephens.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,672.60 -141.38 -0.79%
S&P 500 2,051.82 -11.33 -0.55%
NASDAQ 4,757.8790 +7.4820 0.16%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs